Authors: Kimberley Ndungu (Future Science Group) & Sharon Salt, Editor
At the NCRI Cancer Conference (3–5 November 2019, Glasgow, UK), researchers have presented data that demonstrates how chemical analysis of blood samples, coupled with an artificial intelligence program, could speed up brain tumor diagnosis.
Due to the ambiguous symptoms presented by individuals with brain tumors, such as headaches or memory problems, brain scans remain the only reliable technique for diagnosis. Finding new ways to efficiently diagnose and treat brain tumors remains an urgent need, particularly as the number of related mortalities is increasing.
In this research, the investigators commented on how their new test could improve brain tumor survival by making diagnosis quicker and more efficient.